Severe Bradycardia Leading to Hemodynamic Instability Associated with Remdesivir Use in a Patient with COVID-19 Pneumonia

Remdesivir (RDV) is an approved treatment for hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. There is limited literature on the cardiac adverse effects of RDV. We report a case of a patient who developed hemodynamically unstable bradycardia after t...

Descripción completa

Detalles Bibliográficos
Autores principales: Donepudi, Bhargavi, Agarwal, Shikhar, Thakur, Lokendra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578912/
https://www.ncbi.nlm.nih.gov/pubmed/36267193
http://dx.doi.org/10.1155/2022/8807957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578912/
https://www.ncbi.nlm.nih.gov/pubmed/36267193
http://dx.doi.org/10.1155/2022/8807957

Ejemplares similares